Oxular is actively partnering with industry peers to utilize the potential of our technology across multiple modalities and indications.
Our drug administration technology enables routine administration to deliver drugs to specific back-of-eye tissues, including the suprachoroidal spaces.
Our drug formulations are designed to suit the unique ocular environments into which they are delivered, resulting in better kinetics and therapeutic benefits. They can provide treatment effects lasting up to 12 months from a single administration.
If you would like to discuss a potential partnership with Oxular, please contact us via the form linked below.
Our Site
General Contact
+44 (0)1865 636200
Magdalen Centre
1 Robert Robinson Avenue
Oxford, OX4 4GA, UK
Media Contact
Ben Atwell / Alex Davis
FTI Consulting
London
Limited company registered in England and Wales (Registration No. 09331313)
VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting
Follow us on
Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting